Immuneering Appoints Harold E. Brakewood as Chief Business Officer
28. März 2023 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an...